# OnCo record low-dose-nivolumab-tmh (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/low-dose-nivolumab-tmh/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "low-dose-nivolumab-tmh" ;
  schema:name "Low-dose nivolumab plus metronomic chemotherapy (Tata Memorial)"@en ;
  schema:description "A Mumbai trial that added about one-twentieth of the usual dose of the immunotherapy nivolumab to cheap oral chemotherapy and nearly tripled the share of patients alive at one year."@en ;
  schema:url <https://onco.cc/trials/low-dose-nivolumab-tmh/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.22.01015> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/>, <https://onco.cc/cancers/buccal-mucosa-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/methotrexate/> ;
  onco:institutions <https://onco.cc/institutions/tata-memorial/> ;
  onco:terms <https://onco.cc/terms/os/> ;
  onco:people <https://onco.cc/people/patil-vijay/>, <https://onco.cc/people/prabhash-kumar/>, <https://onco.cc/people/noronha-vanita/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dose-optimisation/>, <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-global-access/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-patil-low-dose-nivolumab-jco-2023/> .